A 35-year-old nulliparous woman with a 10-year history of dysmenorrhea and heavy menstrual bleeding (HMB) presents to the gynecology clinic. She has tried NSAIDs and combined oral contraceptives without adequate relief. Her pelvic ultrasound is normal (no fibroids or adenomyosis). She is counseled about IUCDs and asks which device would be most beneficial for her symptoms. What is the most appropriate recommendation?

Explanation

## Clinical Problem This patient has **dysmenorrhea and heavy menstrual bleeding (HMB)** despite medical management. She is nulliparous, which raises questions about IUCD eligibility and choice. The goal is to select the device that addresses her symptoms. ## Effect of IUCDs on Menstrual Symptoms | Symptom | Copper IUCD | LNG-IUD | |---------|-------------|----------| | **Menstrual bleeding** | Increased by 30–50% | Reduced by 70–90%; amenorrhea in 60–80% by year 1 | | **Dysmenorrhea** | Worsened or unchanged | Improved in 60–80% of users | | **Mechanism** | Foreign body reaction; increased PGF~2α~ | Direct endometrial suppression; atrophy | | **Cycle regularity** | Regular but heavier | Irregular initially; often amenorrheic | **Key Point:** LNG-IUD is the **gold-standard IUCD for HMB and dysmenorrhea** because it suppresses the endometrium directly, reducing bleeding by 70–90% and improving dysmenorrhea in the majority of users. Copper IUCD would **worsen** her symptoms. ## Nulliparity and IUCD Insertion **High-Yield:** Nulliparity is **no longer a contraindication** to IUCD insertion. Current guidelines (WHO, ACOG, FIGO) recommend IUCDs as first-line LARC for all women, including nulliparous women, provided there is no history of pelvic infection or ectopic pregnancy. **Clinical Pearl:** Nulliparous women may experience slightly more insertion discomfort and have a marginally higher expulsion rate (~5–8% vs. 2–5% in multiparous women), but complication rates (perforation, infection) are similar. The benefits of LARC far outweigh insertion-related concerns. ## Why LNG-IUD Is Optimal Here 1. **Addresses HMB:** Reduces menstrual blood loss by 70–90% 2. **Improves dysmenorrhea:** Endometrial suppression reduces PGF~2α~ and uterine contractions 3. **High efficacy:** >99% contraceptive effectiveness 4. **Reversible:** Fertility returns quickly after removal 5. **Cost-effective:** Reduces need for hysterectomy or other interventions **Mnemonic:** **HELM** — **H**eavy bleeding, **E**ndometrial suppression, **L**NG-IUD, **M**enstrual symptom relief. ## Addressing Distractors - Copper IUCD would **exacerbate** HMB and dysmenorrhea due to increased prostaglandin release and foreign body inflammation. - Nulliparity is not a contraindication; insertion complication rates are similar in nulliparous and multiparous women. - LNG-IUD does not increase infertility risk; it is reversible and does not damage the endometrium permanently. [cite:Park 26e Ch 8; ACOG Committee Opinion 735]